Impax announced the launch of Metaxalone Tablets, the generic version of Pfizer‘s Skelaxin.

Metaxalone, a muscle relaxant (central), is indicated as an adjunct to rest, physical therapy, and other remedies for relief of discomfort associated with acute, painful musculoskeletal conditions. It has no direct action on the contracting mechanism of striated muscle, nerve fiber or on the motor endplate, but its mechanism of action is believed to be associated with general central nervous system depression. 

Related Articles

Metaxalone will be available in 400mg and 800mg strength tablets in 100-count bottles.

For more information visit